Coaching program to help breast cancer survivors return to work

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of a coaching program designed to support breast cancer patients in their return to work after completing adjuvant treatment. Participants will undergo an individual interview to assess their needs, followed by seven coaching workshops spaced over several weeks. The program aims to improve quality of life and reduce psychological distress, with assessments conducted before, one month after, and six months after the workshops. The study also seeks to measure recruitment rates and participant satisfaction with the program.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy)
* Patient who has completed adjuvant treatment, except for hormonotherapy
* Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis
* Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field
* Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job
* Patient who signed the informed consent after informed information by her clinician

Exclusion Criteria:

* Metastatic breast cancer or any other cancer within the last 5 years
* Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy)
* Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study
* Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test)
* Physical inability to answer questionnaires

Where it's running

• Institut du Cancer de Montpellier
  Montpellier, France Recruiting

Study contacts

• Study coordinator: Jean-Pierre Bleuse
• Email: jean-pierre.bleuse@icm.unicancer.fr
• Phone: 04 67 61 31 02

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.